Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways

EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma

Michael Weller, Martin J. van den Bent, Kirsten Hopkins et al. · The Lancet Oncology · 2014 · 755 citations · Full text

Medicine, Neurosurgery, Oncology +14

Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas

Wilko Weichert, Carsten Denkert, Aurelia Noske et al. · Neoplasia · 2008 · 179 citations · Full text

Medicine, Oncology, Pathology +13

Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas

Agda K. Lucio-Eterovic, Maria AA Cortez, Elvis Terci Valera et al. · BMC Cancer · 2008 · 154 citations · Full text

Medicine, Cancer Biology, Oncology +14

miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways

Zhenlin Liu, Zhongmin Jiang, Jianyong Huang et al. · International Journal of Oncology · 2014 · 138 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylases

Eun Jung Choi, Bong Jun Cho, David Lee et al. · BMC Cancer · 2014 · 116 citations · Full text

Medicine, Oncology, Pharmacology +17